Cochlear® Nucleus® Nexa® System Named One of TIME's Best Inventions of 2026prnewswire·Oct 20, 2026 at 11:41 AMCHEOY+0.65%
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026prnewswire·Oct 14, 2026 at 03:05 PMCHEOY+0.65%
Morgan Stanley Reaffirms Their Hold Rating on Cochlear (CHEOF)Tip Ranks·Oct 1, 2026 at 12:35 AMCHEOY+0.65%
Cochlear And 2 Other Australian Healthcare Stocks To OwnSimplywall·Sep 30, 2026 at 11:16 AMCHEOY+0.65%MESO+1.59%
Macquarie Sticks to Its Hold Rating for Cochlear (CHEOF)Tip Ranks·Sep 30, 2026 at 01:05 AMCHEOY+0.65%
Cochlear Reaches More Than 1 Million Hours of Patient Experience Across Its Fully Implantable Hearing Technology Research ProgramUnusual Whales·Sep 28, 2026 at 06:08 PMCHEOY+0.65%
Cochlear completes recruitment for global pivotal trial of fully implantable hearing systemPUBT·Sep 28, 2026 at 06:01 PMCHEOY+0.65%
COH: Underlying net profit fell 22% to $322M on flat revenue, with FY27 guidance for modest growthQuartr·Aug 17, 2026 at 09:53 PMCHEOY+0.65%
How Investors Are Reacting To Cochlear (ASX:COH) FDA Approval Of Its Rechargeable Osia 3 ProcessorSimplywall·Jul 14, 2026 at 05:01 PMCHEOY+0.65%
Ord Minnett Reaffirms Their Hold Rating on Cochlear (CHEOF)Tip Ranks·Jul 2, 2026 at 01:05 AMCHEOY+0.65%
Cochlear (ASX:COH) Shares Could Be 44% Below Fair Value After 2026 Guidance CutSimplywall·Jun 19, 2026 at 03:06 PMCHEOY+0.65%
